NovoCure LimitedNVCRNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
8.33%
↑ 232% above average
Average (39q)
-6.30%
Historical baseline
Range
High:350.00%
Low:-415.70%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 8.33% |
| Q2 2025 | -16.13% |
| Q1 2025 | 49.18% |
| Q4 2024 | -117.86% |
| Q3 2024 | 9.68% |
| Q2 2024 | 13.89% |
| Q1 2024 | 18.18% |
| Q4 2023 | 4.35% |
| Q3 2023 | 14.81% |
| Q2 2023 | -8.00% |
| Q1 2023 | -38.89% |
| Q4 2022 | -44.00% |
| Q3 2022 | -8.70% |
| Q2 2022 | -415.70% |
| Q1 2022 | 82.16% |
| Q4 2021 | -92.31% |
| Q3 2021 | 7.14% |
| Q2 2021 | -248.26% |
| Q1 2021 | -180.40% |
| Q4 2020 | -44.44% |
| Q3 2020 | 350.00% |
| Q2 2020 | -50.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 100.00% |
| Q3 2019 | 251.52% |
| Q2 2019 | 89.85% |
| Q1 2019 | 23.53% |
| Q4 2018 | -30.77% |
| Q3 2018 | 23.53% |
| Q2 2018 | 26.09% |
| Q1 2018 | -91.67% |
| Q4 2017 | 7.69% |
| Q3 2017 | 45.83% |
| Q2 2017 | -14.29% |
| Q1 2017 | 19.23% |
| Q4 2016 | 33.33% |
| Q3 2016 | 18.75% |
| Q2 2016 | -14.29% |
| Q1 2016 | -7.69% |
| Q4 2015 | -25.81% |